Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49.70B | $54.28B | $52.20B | $66.90B | $46.36B | $13.54B | $20.54B | $20.84B | $17.04B | $11.01B | $11.53B |
| Research & development | — | — | — | — | — | — | $20.0M | $25.0M | $36.0M | $36.0M | $27.0M |
| Operating expenses | $6.34B | $6.84B | $6.35B | $5.82B | $4.72B | $1.96B | $2.09B | $2.18B | $1.95B | $1.24B | $1.28B |
| Net income | $3.92B | $3.11B | $4.07B | $6.42B | $553.0M | −$2.38B | $2.19B | −$2.67B | $3.37B | −$545.0M | $618.0M |
| Basic EPSper diluted share | CA$2.16 | CA$1.68 | CA$2.15 | CA$3.29 | CA$0.27 | -CA$1.94 | CA$1.78 | -CA$2.17 | CA$3.05 | -CA$0.65 | CA$0.75 |
| Diluted EPSper diluted share | CA$2.15 | CA$1.67 | CA$2.09 | CA$3.20 | CA$0.27 | -CA$1.94 | CA$1.78 | -CA$2.17 | CA$3.05 | -CA$0.65 | CA$0.75 |